Vantrexa · SCLC · Germany · Radiation oncologist · captured by Rachel Adeyemi on 10 May 2026 · reviewed by Dr. Marcus Lindqvist on 16 May 2026
Marked as duplicate
Verbatim as captured; never edited
Radiation oncologist at Universitätsklinikum Heidelberg raised brain-metastasis subgroup data during a scientific exchange. They asked whether additional data would be presented at the next congress.
Human-approved by Dr. Marcus Lindqvist on 16 May 2026
Brain-metastasis subgroup data: interest in collaboration reported by radiation oncologist (DE).
helixor-private-llm-2026.05 · generated 10 May 2026, 10:00 UTC
AI summary
Brain-metastasis subgroup data raised by radiation oncologist; aligns with Clinical Development.
Source spans used by the model
Radiation oncologist at Universitätsklinikum Heidelberg raised brain-metastasis subgroup data during a scientific exchange. They asked whether additional data would be presented at the next congress.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Efficacy | Efficacy |
| Function | Clinical Development | Clinical Development |
| Priority | Medium | Medium |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 3 | 20% | 12.0 |
| Strategic alignment | 4 | 20% | 16.0 |
| Scientific importance | 2 | 15% | 6.0 |
| Urgency | 2 | 15% | 6.0 |
| Novelty | 5 | 10% | 10.0 |
| Actionability | 3 | 10% | 6.0 |
| Confidence | 2 | 5% | 2.0 |
| Breadth of occurrence | 2 | 5% | 2.0 |
| Total | Medium 60 | ||
| Time | Action | User | Field | Change | Reason | Source |
|---|---|---|---|---|---|---|
| 14 Sept 2026, 08:47 UTC | Update | RARachel Adeyemi | status | In progress → Reviewed | — | UI |
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
10 May 2026 · Dr. William Abbott, Universitätsklinikum Heidelberg · MSL Rachel Adeyemi
Insight
Reviewed 16 May 2026 by Dr. Marcus Lindqvist
Action
Initiative
Decision
Outcome
Closure
Duplicate theme merged into strategic objective review.
Duplicate of INS-0039 — Interest in IIS on lumevarin in chronic migraine with medication-overuse headache; population under-represented in trials.